Insider · CIK 0001948795
Michael J Rossi
Files at YMAB (Y-mAbs Therapeutics, Inc.). First filing -, latest -.
In brief
Michael J Rossi files SEC Form 4 as CEO, president and director at YMAB (Y-mAbs Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Michael J Rossi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 7, 2025 | YMAB Y-mAbs Therapeutics, Inc. | 3,917 0.01% of outstanding | $20k | Mar 7, 2025 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | UTender of shares Common Stock | -7,982 | $8.60 | $69k | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Common Stock | -129,101 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -615,240 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -214,200 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -210,700 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -18,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -18,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -18,000 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -52,650 | - | - | 0 | Sep 18, 2025 |
| Sep 16, 2025 | YMAB Y-mAbs Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -52,650 | - | - | 0 | Sep 18, 2025 |
Questions about Michael J Rossi
Answered from the filings on this page, as of the latest one.
Is Michael J Rossi buying or selling?
Michael J Rossi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Michael J Rossi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael J Rossi has 0.
Where does Michael J Rossi file Form 4?
Michael J Rossi has filed Form 4 at YMAB (Y-mAbs Therapeutics, Inc.) as PRESIDENT & CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.